Group 1 - Defu Technology plans to acquire at least 51% of Huiru Technology through cash purchase and capital increase, aiming for rapid capacity expansion to meet growing downstream demand [2] - Huiru Technology specializes in the R&D, production, and sales of high-performance electrolytic copper foil, with a current production capacity of 20,000 tons per year [2] - East China Pharmaceutical's subsidiary, Daor Biotechnology, has its product DR10624 included in the list of breakthrough therapeutic varieties, targeting severe hypertriglyceridemia [3][18] - DR10624 is a globally first-of-its-kind long-acting tri-specific agonist, showing excellent efficacy in reducing triglycerides and eliminating liver fat in clinical trials [3][18] Group 2 - Xiantan Co. reported a 9.41% year-on-year increase in chicken product sales revenue, reaching 529 million yuan, with sales volume up by 6.76% [4][19] - Jiamei Packaging's stock will resume trading on January 12 after completing a review during its suspension, with a significant price increase of 230.48% during the suspension period [5][20] - Xianle Health plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange, considering the interests of existing shareholders [6][21][22] Group 3 - China Shipbuilding Defense expects a net profit increase of 149.61% to 196.88% for 2025, projecting a profit of 940 million to 1.12 billion yuan [7][23] - Daotong Technology anticipates a net profit growth of 40.42% to 45.10% for 2025, with a projected profit of 900 million to 930 million yuan [8][24] - Huace Navigation forecasts a net profit increase of 14.84% to 18.27% for 2025, estimating a profit of 670 million to 690 million yuan [9][25] Group 4 - Luokai Co. won a procurement project from State Grid Fujian Electric Power, with a total contract value of approximately 48.2 million yuan [10][26] - Minhe Co. reported a 65.22% year-on-year increase in the sales volume of commodity broiler chicks, totaling approximately 29.66 million chicks, with sales revenue up by 53.09% [11][27] - Zhenghai Bio obtained a medical device registration certificate for calcium silicate bio-ceramic oral bone repair materials, suitable for alveolar bone defect repair [12][28] - Three Gorges Energy reported a cumulative total power generation increase of 5.99% for 2025, with a total generation of 762.61 billion kWh [13][29] - Huisheng Bio expects a net profit of 235 million to 271 million yuan for 2025, marking a turnaround from a loss in the previous year [14][30]

Major Events - Defu Technology announced the termination of the acquisition of 100% equity in Luxembourg Copper Foil due to additional restrictions imposed by the Luxembourg Ministry of Economy, with a contract deposit of €17.4047 million to be fully refunded within 10 working days after termination [1] - China Nonferrous Mining expects a total copper production of approximately 484,000 tons in 2026, including 134,000 tons of cathode copper and 350,000 tons of crude/anode copper, with a decrease in crude/anode copper production due to planned maintenance [3] - Huadong Medicine's subsidiary, Zhejiang Daor Biotechnology, has its DR10624 injection included in the breakthrough therapy designation list for severe hypertriglyceridemia, with clinical research approvals from China CDE and the US FDA [4] Performance - Xiantan Co. reported chicken product sales revenue of CNY 530 million in December 2025, with a year-on-year increase of 9.41% and a sales volume of 55,100 tons [5] - Jinzizi Liquor expects to report a net loss for the fiscal year 2025, although the loss is anticipated to narrow compared to the previous year [6] - Dechang Co. forecasts a net profit of CNY 160 million to CNY 200 million for 2025, representing a year-on-year decrease of 51% to 61% [7] Stock Suspension and Resumption - Jiamei Packaging's stock will resume trading on January 12, 2026, after a price increase of 230.48% from December 17, 2025, to January 6, 2026, leading to a temporary suspension for investigation [8] - Yanjing Co. continues to suspend trading due to uncertainties related to asset acquisition plans, with an expected disclosure of the transaction plan by January 19, 2026 [9]

证券日报网讯1月11日，仙坛股份（002746）发布公告称，公司2025年12月鸡肉产品销售收入52， 963.33万元、销量5.51万吨，同比增长9.41%、6.76%，环比增长7.29%、降低4.04%。 ...

Company Performance - Xiantan Co., Ltd. reported a chicken product sales revenue of 530 million yuan for December 2025, with a year-on-year growth of 9.41% and a month-on-month growth of 7.29% [1] - The total sales volume for chicken products reached 55,100 tons, reflecting a year-on-year increase of 6.76% and a month-on-month decrease of 4.04% [1] Poultry Farming and Processing Industry - The poultry farming and processing sector achieved a sales revenue of 472 million yuan, with a year-on-year growth of 4.76% and a month-on-month growth of 9.56% [1] - The sales volume in this sector was 51,200 tons, showing a year-on-year increase of 4.07% and a month-on-month decrease of 3.08% [1] Food Processing Industry - The food processing industry generated a sales revenue of approximately 57.66 million yuan, with a significant year-on-year growth of 71.83% and a year-on-year sales volume increase of 63.04% [1] - However, the month-on-month sales revenue and volume experienced declines of 8.28% and 15.36%, respectively [1]

Group 1 - Jia Mei Packaging's stock will resume trading on January 12, 2026, after completing a review due to a 230.48% price increase from December 17, 2025, to January 6, 2026 [1] - Yan Jiang Co. continues to suspend trading as it plans to acquire assets, with a disclosure expected by January 19, 2026 [2] - Defu Technology terminated its acquisition of 100% of Luxembourg Copper Foil due to restrictions from the Luxembourg Ministry of Economy, with a refund of €17.4047 million expected [3] Group 2 - Defu Technology plans to acquire at least 51% of Huiru Technology through cash and capital increase, with Huiru focusing on high-performance electrolytic copper foil [4] - Shangluo Electronics' application for issuing convertible bonds has been accepted by the Shenzhen Stock Exchange [5] - Xianle Health intends to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and capital strength [6] Group 3 - Hangyu Technology plans to sell up to 752,800 repurchased shares to supplement working capital, with a potential cancellation of unsold shares [7] - Fangsheng Pharmaceutical's production facility failed a GMP compliance check, but it will not significantly impact operations [8][9] - East China Pharmaceutical's subsidiary's product has been included in the list of breakthrough therapeutic varieties for severe hypertriglyceridemia [10] Group 4 - Dechang Co. expects a net profit decrease of 51% to 61% for 2025, primarily due to competitive pressures and foreign exchange losses [12] - Hebang Bio anticipates a net loss for 2025 due to asset impairment provisions [13] - Qu Mei Home expects a net loss for 2025, with significant negative figures reported for the first nine months [14] Group 5 - Jinzongzi Wine forecasts a net loss for 2025, although the loss is expected to narrow compared to the previous year [15] - Sichuan Electronics expects a net loss of between 265 million to 340 million yuan for 2025, attributed to market competition and delayed orders [16] - Wansheng Co. anticipates a net loss for 2025 [17] - Weiyuan Co. also expects a net loss for 2025 [19] - Kosen Technology predicts a net loss for 2025 due to low capacity utilization and strategic adjustments [20] - Zhongheng Group expects a net loss for 2025 [21] Group 6 - Xiantan Co. reported a 9.41% year-on-year increase in chicken product sales revenue to 530 million yuan in December 2025 [22] Group 7 - Huate Gas shareholders plan to reduce their holdings by up to 2% through block trades [24] - Meidike shareholders plan to reduce their holdings by up to 1% through market transactions [25]

Company Performance - Xiantan Co., Ltd. reported chicken product sales revenue of 529.63 million yuan for December 2025, with a year-on-year growth of 9.41% and a month-on-month growth of 7.29% [1] - The total sales volume for chicken products reached 55,100 tons, reflecting a year-on-year increase of 6.76% and a month-on-month decrease of 4.04% [1] Industry Breakdown - The poultry farming and processing sector generated chicken product sales revenue of 471.97 million yuan, with a year-on-year growth of 4.76% and a month-on-month growth of 9.56% [1] - The sales volume in this sector was 51,200 tons, showing a year-on-year increase of 4.07% and a month-on-month decrease of 3.08% [1] - The food processing industry achieved chicken product sales revenue of 57.66 million yuan, with a significant year-on-year growth of 71.83% and a sales volume of 3,800 tons, reflecting a year-on-year increase of 63.04% [1] - However, the food processing sector experienced a month-on-month decline in sales revenue by 8.28% and a decrease in sales volume by 15.36% [1]

Core Viewpoint - Xiantan Co., Ltd. (002746.SZ) reported a chicken product sales revenue of 530 million yuan for December 2025, with a sales volume of 55,100 tons, reflecting year-on-year changes of 9.41% and 6.76%, and quarter-on-quarter changes of 7.29% and -4.04% [1] Group 1: Poultry Farming and Processing Industry - The poultry farming and processing sector achieved chicken product sales revenue of 472 million yuan and a sales volume of 51,200 tons, with year-on-year changes of 4.76% and 4.07%, and quarter-on-quarter changes of 9.56% and -3.08% [1] - The pre-offset chicken product sales revenue was 514 million yuan, with a sales volume of 54,300 tons [1] Group 2: Food Processing Industry - The food processing sector reported chicken product sales revenue of 57.66 million yuan and a sales volume of 3,800 tons, with year-on-year changes of 71.83% and 63.04%, and quarter-on-quarter changes of -8.28% and -15.36% [1]

Core Viewpoint - Xiantan Co., Ltd. reported a chicken product sales revenue of 530 million yuan for December 2025, with a sales volume of 55,100 tons, reflecting year-on-year changes of 9.41% and 6.76%, and quarter-on-quarter changes of 7.29% and -4.04% respectively [1] Group 1: Poultry Farming and Processing Industry - The poultry farming and processing industry achieved chicken product sales revenue of 472 million yuan and a sales volume of 51,200 tons, with year-on-year changes of 4.76% and 4.07%, and quarter-on-quarter changes of 9.56% and -3.08% respectively [1] - The pre-offset chicken product sales revenue was 514 million yuan, with a sales volume of 54,300 tons [1] Group 2: Food Processing Industry - The food processing industry generated chicken product sales revenue of 57.66 million yuan and a sales volume of 3,800 tons, with year-on-year changes of 71.83% and 63.04%, and quarter-on-quarter changes of -8.28% and -15.36% respectively [1]

其中，家禽饲养加工行业实现鸡肉产品销售收入4.72亿元，销售数量5.12万吨(注：抵消前的鸡肉产品销 售收入为5.14亿元，销售数量5.43万吨)，同比变动4.76%、4.07%，环比变动9.56%、-3.08%;食品加工行 业实现鸡肉产品销售收入5,765.88万元，销售数量0.38万吨，同比变动71.83%、63.04%，环比变 动-8.28%、-15.36%。 智通财经APP讯，仙坛股份(002746.SZ)发布公告，公司2025年12月实现鸡肉产品销售收入5.3亿元，销 售数量5.51万吨，同比变动幅度分别为9.41%、6.76%，环比变动幅度分别为7.29%、-4.04%。 ...

一、2025 年 12 月份销售情况简报 山东仙坛集团股份有限公司（以下简称"公司"）2025 年 12 月实现鸡肉产品 销售收入 52,963.33 万元，销售数量 5.51 万吨，同比变动幅度分别为 9.41%、 6.76%，环比变动幅度分别为 7.29%、-4.04%。 其中，家禽饲养加工行业实现鸡肉产品销售收入 47,197.45 万元，销售数量 5.12 万吨（注：抵消前的鸡肉产品销售收入为 51,428.34 万元，销售数量 5.43 万吨），同比变动 4.76%、4.07%，环比变动 9.56%、-3.08%；食品加工行业实现 鸡肉产品销售收入 5,765.88 万元，销售数量 0.38 万吨，同比变动 71.83%、 63.04%，环比变动-8.28%、-15.36%。 上述数据未经审计，与定期报告披露的数据之间可能存在差异。因此上述数 据仅作为阶段性数据供投资者参考。 二、原因说明 证券代码：002746 证券简称：仙坛股份 公告编号：2026-001 山东仙坛集团股份有限公司 2025 年 12 月份销售情况简报 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记 载、误 ...